The F@H paper I was a coauthor on (https://www.ncbi.nlm.nih.gov/pubmed/24345941) has been cited by many in pharma. I honestly can't say whether it has directly contributed, but many people have been thankful for this work because it helped establish the concept that proteins aren't super stable rocks, so virtual drug discovery screening can work better if you can simulate the dynamics of a protein (in this case, we simulated a GPCR, which is a common pharma target).
Comments
The F@H paper I was a coauthor on (https://www.ncbi.nlm.nih.gov/pubmed/24345941) has been cited by many in pharma. I honestly can't say whether it has directly contributed, but many people have been thankful for this work because it helped establish the concept that proteins aren't super stable rocks, so virtual drug discovery screening can work better if you can simulate the dynamics of a protein (in this case, we simulated a GPCR, which is a common pharma target).